Rosenberger Brian
- SEC CIK
- 0001695788
No open-market purchases or sales filed in the past year.
Current role at each company
- ZYNE Zynerba Pharmaceuticals, Inc.VP, Commercial & Business Dev.as of Oct 11, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Rosenberger Brian as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 14, 2023 (view filing) | Sep 13 | 1 day | Rosenberger BrianVP, Commercial & Business Dev. | SSale | −6.41K | $1.33 | −$8.53K | −2.5%249.6K after | |
| Jan 25, 2023 (view filing) | Jan 23 | 2 days | Rosenberger BrianVP, Commercial & Business Dev. | SSale | −12.7K | $0.60 | −$7.60K | −11.8%94.8K after | |
| Jul 20, 2022 (view filing) | Jul 19 | 1 day | Rosenberger BrianVP, Commercial & Business Dev. | SSale | −4.29K | $1.10 | −$4.72K | −3.8%107.5K after |